General
Correction from Arab Pharmaceuticals (ADCI.CA) Concerning the Board of Directors' Decisions
Published at 3 May 2026 at 12:07Arab PharmaceuticalsRelated stock:Arab Pharmaceuticals stockAll Arab Pharmaceuticals disclosures
Disclosure summary
Company Name : Arab Pharmaceuticals
ISIN Code : EGS38321C013
Reuters Code : ADCI.CA
Content :
Referring to the announcement published on the trading screens on 30/04/2026 concerning the Board of Directors' decisions held on 29/04/2026, a correction was sent from the company.
Correction from the Company (34 KB)
ISIN Code : EGS38321C013
Reuters Code : ADCI.CA
Content :
Referring to the announcement published on the trading screens on 30/04/2026 concerning the Board of Directors' decisions held on 29/04/2026, a correction was sent from the company.
Correction from the Company (34 KB)